US$ 24.66
dihexa clinical trials safety in Trials: What We've Learned So Far dihexa clinical trials status Hepatocyte
Description
A characterization of white matter pathology following spinal cord compression injury in the rat

Mr Otto, you do not have MS

The epidermal growth factor receptor family: biology driving targeted therapeutics

The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects
